U.S. Markets open in 8 hrs 16 mins

Wall Street Analysts Are Mostly Positive on Jazz Pharmaceuticals

Daniel Collins
Wall Street Analysts Are Mostly Positive on Jazz Pharmaceuticals

In August 2018, Jazz Pharmaceuticals (JAZZ) and the University of Texas MD Anderson Cancer Center entered a five-year collaboration agreement to investigate therapies for the treatment of multiple hematologic malignancies such as AML (acute myeloid leukemia) and myelodysplastic syndrome.